Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers. - Cottu, Paul H.; Bonneterre, Jacques; Varga, Andrea; Campone, Mario; Leary, Alexandra; Floquet, Anne; Berton-Rigaud, Dominique; Sablin, Marie-Paule; Lesoin, Anne; Rezai, Keyvan; Lokiec, François M.; Lhomme, Catherine; et al. (PLoS ONE, 2018)